16:2！ Pfizer's vaccine booster plan was rejected by the FDA, and the company's market value evaporat

Original title: 16:2! Pfizer's vaccine booster plan was rejected by the FDA, and the company's market value evaporated $37 billion a month
Edited by: Li Zedong
According to CCTV news on September 18, on September 17 local time, an expert advisory group of the U.S. Food and Drug Administration (FDA) rejected the plan to inject Pfizer new crown vaccine booster for people aged 16 and over with a vote of 16-2. The group has submitted the voting results to the FDA for final decision.
According to the suggestions of the panellists, the elderly and vulnerable groups may benefit from the booster needle, but there is insufficient data on whether the booster needle is effective for young groups.

As of the close, Pfizer fell 1.39% and lost nearly $3.5 billion in market value. The data showed that Pfizer's market value of $37 billion evaporated in the past month.
According to Xinhua News Agency on September 6, fudge, director of the National Institute of allergy and infectious diseases, said on the 5th that U.S. regulators may approve Pfizer's new crown vaccine booster before September 20, while Modena's new crown vaccine booster may delay approval.

The picture shows Anthony fouch delivering a speech in Washington on July 31, 2020 (Xinhua News Agency)
Xinhua News Agency reported on August 19 that US President Joe Biden announced on the 18th that the United States plans to provide the public with new coronal vaccine booster shots from September 20 to cope with the rebound of the epidemic throughout the United States.
In a speech at the White House that day, Biden said that in the face of variant COVID-19, vaccination is the best way to protect ourselves. Earlier in the day, a number of senior health officials in the United States announced that booster shots could be given eight months after the second shot of Modena or Pfizer vaccine. Information about the booster of Johnson & Johnson vaccine will be released in the coming weeks.
According to the relevant data of the Centers for Disease Control and prevention of the United States, the number of newly diagnosed cases in the United States has increased rapidly since July, with 141893 newly diagnosed cases on August 17; As of the 17th, the daily average number of newly confirmed cases in the seven days was 130121, reaching a new high since February 2 this year. A report released by the American Academy of Pediatrics and children's hospital shows that as of August 12th, at least 4 million 410 thousand children in the United States had been diagnosed with COVID-19, accounting for 14.4% of all confirmed cases.
CDC data show that as of the 18th, 60% of the U.S. population had received at least one dose of the new crown vaccine, and 51% of the population had completed the new crown vaccine.
The daily economic news is reported by CCTV news and Xinhua news agency
Daily economic news